Skip to main content

Application of the new cholesterol guidelines.

Publication ,  Journal Article
Navar-Boggan, AM; Sniderman, AD; Pencina, MJ
Published in: N Engl J Med
July 3, 2014

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

July 3, 2014

Volume

371

Issue

1

Start / End Page

79

Location

United States

Related Subject Headings

  • Practice Guidelines as Topic
  • Male
  • Hypercholesterolemia
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • General & Internal Medicine
  • Female
  • Cardiovascular Diseases
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Navar-Boggan, A. M., Sniderman, A. D., & Pencina, M. J. (2014). Application of the new cholesterol guidelines. N Engl J Med, 371(1), 79. https://doi.org/10.1056/NEJMc1405680
Navar-Boggan, Ann Marie, Allan D. Sniderman, and Michael J. Pencina. “Application of the new cholesterol guidelines.N Engl J Med 371, no. 1 (July 3, 2014): 79. https://doi.org/10.1056/NEJMc1405680.
Navar-Boggan AM, Sniderman AD, Pencina MJ. Application of the new cholesterol guidelines. N Engl J Med. 2014 Jul 3;371(1):79.
Navar-Boggan, Ann Marie, et al. “Application of the new cholesterol guidelines.N Engl J Med, vol. 371, no. 1, July 2014, p. 79. Pubmed, doi:10.1056/NEJMc1405680.
Navar-Boggan AM, Sniderman AD, Pencina MJ. Application of the new cholesterol guidelines. N Engl J Med. 2014 Jul 3;371(1):79.

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

July 3, 2014

Volume

371

Issue

1

Start / End Page

79

Location

United States

Related Subject Headings

  • Practice Guidelines as Topic
  • Male
  • Hypercholesterolemia
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • General & Internal Medicine
  • Female
  • Cardiovascular Diseases
  • 42 Health sciences
  • 32 Biomedical and clinical sciences